{"SPADE_UN_28468": {"Sequence Information": {"Peptide Name": "Histatin 5 (4-15), P-113", "Sequence": "AKRHHGYKRKFH", "Sequence Length": 12, "Biological Activity": ["Anti-Gram+", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P15516", "uniprotUrl": "http://www.uniprot.org/uniprot/P15516", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane", "Pubmed ID": "17485465", "Reference": "J Biol Chem. 2007;282:18831-18841", "Author": "Veerman EC, Valentijn-Benz M, Nazmi K, Ruissen AL, Walgreen-Weterings E, van Marle J, Doust AB, van't Hof W, Bolscher JG, Amerongen AV", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17485465"}, {"Title": "Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5", "Pubmed ID": "11302797", "Reference": "Antimicrob Agents Chemother. 2001;45:1367-1373", "Author": "Rothstein DM, Spacciapoli P, Tran LT, Xu T, Roberts FD, Dalla Serra M, Buxton DK, Oppenheim FG, Friden P", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/11302797"}, {"Title": "Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo.", "Pubmed ID": "17620386", "Reference": "Antimicrob Agents Chemother. 2007;51:3416-3419", "Author": "Welling MM, Brouwer CP, van 't Hof W, Veerman EC, Amerongen AV", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17620386"}, {"Title": "Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans.", "Pubmed ID": "21382611", "Reference": "Arch Oral Biol. 2011;56:869-876", "Author": "Huo L, Zhang K, Ling J, Peng Z, Huang X, Liu H, Gu L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21382611"}, {"Title": "In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.", "Pubmed ID": "15073161", "Reference": "J Antimicrob Chemother. 2004;53:750-758", "Author": "Wei GX, Bobek LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15073161"}], "Mass": 1564.8, "PI": 11.17, "Net Charge": 8, "Hydrophobicity": -2.28, "Frequent Amino Acids": "HKR", "Absent Amino Acids": "CDEILMNOPQSTUVW", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 10, "Positive Residues": 8, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28468", "Similar Sequences": [{"SPADE_ID": "SPADE_N_03135", "Similarity": 1.0, "Sequence": "DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN"}, {"SPADE_ID": "SPADE_N_03137", "Similarity": 1.0, "Sequence": "DSHAKRHHGYKRKFHEKHHSHRGY"}, {"SPADE_ID": "SPADE_N_03138", "Similarity": 1.0, "Sequence": "DSHAKRHHGYKRKFHEKHHSHRGYR"}], "Hemolytic Activity": "Human erythrocytes:1% Hemolysis=100 µM", "Target Organism": "Candida albicans ATCC 10231(LC50=2.7µM),Candida albicans ATCC 10231(LC50=>100µM),Candida albicans ATCC 44505(LD50=3.9±0.63µg/ml),Candida albicans ATCC 44505(LD90=7.8±1.33µg/ml),Staphylococcus aureus ATCC 25923(LC50=12.5µM),Staphylococcus aureus 2141(LC50=18.6µM),Streptococcus mutans UA159(MIC=27.29±10.56µM),Streptococcus mutans GS-5(MIC=40.92±22.41µM),Streptococcus gordonii ATCC 10558(MIC=37.52±8.35µM),Streptococcus sanguinis ATCC 49295(MIC=75.03±16.71µM),Candida albicans ATCC 96112(MIC=3.13µg/ml),Candida albicans(MIC=6.25µg/ml),Candida glabrata ATCC 90030(MIC=25.0µg/ml),Candida glabrata 65C(MIC=6.25µg/ml),Cryptococcus neoformans CN2(MIC=3.13µg/ml),Cryptococcus neoformans ATCC 52817(MIC=6.25µg/ml),Saccharomyces cerevisiae S288C(MIC=3.13µg/ml)"}}}